Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preliminary results for the year ended 31 October

28 Jan 2010 07:00

RNS Number : 2444G
Arden Partners plc
28 January 2010
 



Immediate Release

28 January 2010

Arden Partners plc

("Arden" or the "Company")

Preliminary results for the year ended 31 October 2009

Arden Partners plc (AIM: ARDN), the institutional stockbroking company, today announces preliminary results for the year ended 31 October 2009.

Financial highlights

Revenue £13.1 million (2008: £11.4 million)

Underlying profit before tax* £2.2 million (2008: £2.1 million)

Underlying basic earnings per share** 8.0p (2008: 6.1p)

Net cash £10.5m (2008: £9.5m)

Profit before tax as adjusted for the effect of share based payments

**  Basic earnings per share as adjusted for the after-tax effect of share based payments

Operational highlights

Increased client brokerships from 30 to 39

Sixteen transactions completed during the year, comprising nine M&A,  six secondary fundraisings, and one IPO

Equities revenue increased by 31%

Commenting on the results and Arden's outlook, Sir David Rowe-Ham, Chairman, said:

"There is no doubt that this has been a challenging year for the City, however the second half of our financial year has reflected an improvement in market conditions and the Board is satisfied with the overall results. We have a strong balance sheet and have generated cash and improved profitability. We closed the year with a cash balance of £10.5 million.

Trading since our year end has been satisfactory. While volumes in the market have been low we have seen a number of corporate transactions complete and we have a satisfactory pipeline of new business subject to market conditions."

Arden Partners plc 020 7614 5900

Jonathan Keeling - Chief Executive Officer

Trevor Norris - Finance Director

Altium 020 7484 4040

Phil Adams / Sam Fuller

Buchanan Communications 020 7466 5000

Mark Edwards

  

Chairman's Statement

There is no doubt that this has been a challenging year for the City, however the second half of our financial year has reflected an improvement in market conditions and the Board is satisfied with the overall results. We have a strong balance sheet and have generated cash and improved profitability. We closed the year with a cash balance of £10.5 million.

Current market conditions represent a significant opportunity for the business to grow. We have continued to recruit high calibre staff in all areas of the business. We continue to increase market sector coverage as part of our strategy for growth. The withdrawal of a number of investment banks from the small and mid cap markets has provided opportunities for the Group to not only recruit staff but to also win corporate clients and gain market share, capitalising on these opportunities is a key aspect of our growth strategy. 

Trading since our year end has been satisfactory. While volumes in the market have been low we have seen a number of corporate transactions complete and we have a satisfactory pipeline of new business subject to market conditions. For the year ended 31 October 2009 the Board has decided to invest within growth areas of the business and to take advantage of such opportunities rather than pay a final dividend. We believe this policy will be of long-term benefit to our shareholders.

Finally, I would like to thank all staff and clients for their commitment to the business.

Sir David Rowe-Ham

Chairman

Chief Executive's Statement

Introduction

I am pleased to report that the Group has had a satisfactory year in a challenging market. The profit before tax result of £1.5m should be read within the context of a first-half loss before tax of £0.3m.

Financial Review

Revenue in the year ended 31 October 2009 was up by 15% to £13.1m (2008: £11.4m). Underlying profit before tax increased by 5% to £2.2m (2008: £2.1m). Profit before tax, which is stated after charging share-based payments, is up 7% to £1.5m (2008: £1.4m). Cash generation was again strong with balances at the year end of £10.5m (2008: £9.5m) which represented some 370% of our regulatory capital requirement.

Underlying basic earnings per share (before charging share based payments) increased by 31% to 8.0p (2008: 6.1p) with underlying diluted earnings per share increasing by 36% to 7.5p (2008: 5.5p). Basic earnings per share increased by 65% to 5.1p (2008: 3.1p).

Equities Division

Our Equities Division revenue increased by 31% to £8.5m (2008: £6.5m) against an increase in the FTSE All Share index of 18% over the same period. Since the year end, commission income levels have been satisfactory.

Corporate Finance

During the year we completed sixteen corporate finance transactions (2008: twelve) including nine M&A, six secondary fundraisings and one IPO.

Outlook

The current year has started satisfactorily and Arden has to date raised some £111m for corporate clients. We have relocated our main office to 125 Old Broad Street which provides the space and infrastructure for future growth.

Finally, I would like to take this opportunity to thank our staff for their commitment through challenging conditions.

Jonathan Keeling

Chief Executive Officer

Consolidated Income Statement

For the year ended 31 October 2009

2009

2008

Note

£'000

£'000

Revenue

2

13,059

11,431

Administrative expenses 

(11,622)

(10,541)

Profit from operations

1,437

890

Finance income 

86

509

Finance costs

(1)

-

Profit before taxation

1,522

1,399

Income tax expense

(276)

(652)

Profit after taxation

1,246

747

Earnings per share

Basic

4

5.1p

3.1p

Diluted

4

4.8p

2.8p

Consolidated Balance Sheet

At 31 October 2009

2009

2009

2008

2008

£'000

£'000

£'000

£'000

Assets

Non-current assets

Property, plant and equipment

258

323

Deferred tax asset

618

88

Total non-current assets

876

411

Current assets

Trading investments

2,660

220

Trade and other receivables

15,660

3,146

Cash and cash equivalents

10,523

9,481

Total current assets

28,843

12,847

Total assets

29,719

13,258

Current liabilities

Trade and other payables

(17,182)

(2,943)

Corporation tax liability

(685)

(197)

Total current liabilities

(17,867)

(3,140)

Non-current liabilities

Deferred tax  liability

(44)

-

Total non-current liabilities

(44)

-

Total liabilities

(17,911)

(3,140)

Net assets 

11,808

10,118

Equity

Called up share capital

2,494

2,470

Share premium account

2,736

2,646

Employee Benefit Trust Reserve

(648)

(200) 

Available for sale reserve

-

(2)

Retained earnings

7,226

5,204

Total equity

11,808

10,118

Consolidated Cash Flow Statement

For the year ended 31 October 2009

2009

2008

£'000

£'000

Operating activities before taxation

Net profit before tax

1,522

1,399

Adjustments for:

Fair value adjustments

(116)

(38)

Depreciation

256

278

Profit on disposal of available for sale investments

-

(218)

Impairment of available for sale investments

20

342

Net interesreceivable

(85)

(509)

Share based payments

702

584

Operating cash flow before changes in working capital

2,299

1,838

(Increase)/decrease in trade and other receivables

(12,525)

6,564

(Increase)/decrease in financial assets

(2,313)

1,520

Increase/(decrease) in trade and other payables

14,235

(6,079)

Purchases of available for sale investments

(27)

(108)

Proceeds from disposal of available for sale investments

-

368

Cash generated from operations

1,669

4,103

Income taxes paid

(200)

(1,277)

Cash flows from operating activities

1,469

2,826

Investing activities

Purchases of property, plant and equipment

(191)

(89)

Interest received

98

499

Net cash from investing activities

(93)

410

Financing activities

Purchase of own shares

(448)

-

Issue of shares

114

-

Dividends paid to equity shareholders

-

(1,610)

Net cash from financing activities

(334)

(1,610)

Increase in cash and cash equivalents

1,042

1,626

Cash and cash equivalents at the beginning of the year

9,481

7,855

Cash and cash equivalents at the end of the year

10,523

9,481

Consolidated Statement of changes in equity

For the year ended 31 October 2009

Share

Capital

Share

Premium

Account

Employee

Benefit Trust

reserve

Available

for sale

reserve

Retained

earnings

Total

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 31 October 2008

2,470

2,646

(200)

(2)

5,204

10,118

Changes in equity for 2009:

Increase in fair value of  investments

-

-

-

2

-

2

Tax taken to equity

-

-

-

-

74

74

Net income recognised 

directly in equity

-

-

-

2

74

76

Profit for the year

-

-

-

-

1,246

1,246

Total recognised income and expense for the year

-

-

-

2

1,320

1,322

Share based payments

-

-

-

-

702

702

Issue of shares

24

90

-

-

-

114

Purchase of own shares

-

-

(448)

-

-

(448)

Balance at 31 October 2009

2,494

2,736

(648)

-

7,226

11,808

Consolidated Statement of changes in equity 

For the year ended 31 October 2008

Share

Capital

Share

Premium

Account

Employee

Benefit Trust

reserve

Available

for sale

reserve

Retained

earnings

Total

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 31 October 2007

2,470

2,646

(200)

35

5,893

10,844

Changes in equity for 2008:

Available for sale investments:

- Increase in fair value of  investments

-

-

-

156

-

156

- Gain transferred to the  income statement on disposal of investments

-

-

-

(218)

-

(218)

Tax taken to equity

-

-

-

25

(410)

(385)

Net income recognised 

directly in equity

-

-

-

(37)

(410)

(447)

Profit for the year

-

-

-

-

747

747

Total recognised income and expense for the year

-

-

-

(37)

337

300

Dividends

-

-

-

-

(1,610)

(1,610)

Share based payments

-

-

-

-

584

584

Balance at 31 October 2008

2,470

2,646

(200)

(2)

5,204

10,118

Notes

The Employee Benefit Trust reserve represents shares held in the parent company by the Arden Partners Employee Benefit Trust, which is consolidated in these financial statements.

The Available for Sale reserve represents unrealised gains and losses on available for sale investments, being the difference between the acquisition cost and fair value at the balance sheet date. The reserve is shown net of related deferred tax.

NOTES

1) Basis of preparation

The financial information set out in this announcement has been prepared in accordance with the recognition and measurement principles of IFRS as endorsed for use in the European Union.

The financial information set out in this announcement does not constitute the group's statutory accounts for the year ended 31 October 2009 or the year ended 31 October 2008 under the meaning of s434 Companies Act 2006, but is derived from the 2009 annual report and accounts. 

Statutory accounts for the years ended 31 October 2008 and 31 October 2009 have been reported on by the Independent Auditors. 

The Independent Auditors' Report on the Annual Report and Financial Statements for year ended 31 October 2008 was unqualified, did not draw attention to any matters by way of emphasis, and did not contain a statement under 237(2) or 237(3) of the Companies Act 1985. 

The Independent Auditors' Report on the Annual Report and Financial Statements for year ended 31 October 2009 was unqualified, did not draw attention to any matters by way of emphasis, and did not contain a statement under 498(2) or 498(3) of the Companies Act 2006. 

Statutory accounts for the year ended 31 October 2008 have been filed with the Registrar of Companies. The statutory accounts for the year ended 31 October 2009 will be delivered to the Registrar in due course.

2) Revenue

Revenue is wholly attributable to the principal activity of the Group and arises solely within the United Kingdom.

2009

2008

£'000

£'000

Equities Division

8,456

6,547

Corporate Finance Division

4,603

4,884

Total revenue

13,059

11,431

Included within revenue of the Corporate Finance Division is an amount of £155,000 (2008: £nil) relating to the fair value adjustment of derivatives held within trading investments that are fair valued through the income statement.

The Directors are of the opinion that there are only two business segments and that business resources cannot be readily allocated to segments for the purposes of deriving either profit or net assets.

3) Employees

Staff costs (including Directors) of the Group consist of:

2009

2008

£'000 

£'000 

Wages and salaries

4,100

3,790

Incentive payments

944

610

Share based payments 

702

584

Social security costs

582

496

Other pension costs

419

349

6,747

5,829

The average number of employees (including Directors) of the Group during the year was 55 (2008: 51) of which 41 (2008: 40) are front-office and the remainder are administration.

4) Earnings per Share

In addition to the basic earnings per share, underlying earnings per share has been shown because the Directors consider that this gives a more meaningful indication of the underlying performance of the Group. Where applicable, all adjustments are stated after taking into consideration the appropriate tax treatment.

Year ended

31 October 2009

Year ended

31 October 2008

Pence per

Share

Numerator

£'000

Pence per

Share

Numerator

£'000

Basic Earnings

5.1

1,246

3.1

747

Add: IFRS2 share-based payments

2.9

702

2.5

584

Add: Aborted bid costs

-

-

0.5

131

Underlying Basic Earnings

8.0

1,948

6.1

1,462

Diluted Earnings

4.8

1,246

2.8

747

Add: IFRS2 share-based payments

2.7

702

2.2

584

Add: Aborted bid costs

-

-

0.5

131

Underlying Diluted Earnings

7.5

1,948

5.5

1,462

Year ended 31 October 2009

Year ended

31 October 2008

Number

Number

Denominator

Weighted average number of shares in issue for Basic Earnings calculation

24,209,343

24,032,272

Weighted average dilution for outstanding share options

1,828,105

2,340,528

Weighted average number for Diluted Earnings calculation

26,037,448

26,372,800

The shares held by the Arden Partners Employee Benefit Trust have been treated as cancelled and excluded from the denominator. The comparative has been restated to reflect this treatment.

5) Annual Report and Accounts

 

Copies of the 2009 Report and Accounts will be posted to shareholders in due course.  Copies will also be available from the Company's registered office and from the Company's website.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR DMGZMLNFGGZM
Date   Source Headline
28th Apr 202210:15 amRNSOffer Update - Scheme of Arrangement - Effective
28th Apr 20227:30 amRNSSuspension - Arden Partners PLC
28th Apr 20227:00 amRNSNomad register change - Arden Partners Plc
27th Apr 20224:30 pmRNSOffer Update-Court Sanction, Scheme of Arrangement
27th Apr 20224:30 pmRNSOffer Update - Court Sanction of Scheme
21st Apr 20225:30 pmRNSInce Group
19th Apr 20222:00 pmRNSOffer Update – Extension of FCA approval
19th Apr 20222:00 pmRNSExtension of FCA Change of Control Approval
14th Apr 20227:00 amRNSOffer Update - Timetable for completion of Scheme
14th Apr 20227:00 amRNSOffer Update - Timetable for Completion of Scheme
12th Apr 202211:55 amRNSForm 8.5 (EPT/NON-RI)
11th Apr 20227:00 amRNSOffer update – Waiver of NOMAD condition
11th Apr 20227:00 amRNSOffer Update - Waiver of NOMAD Condition
8th Apr 20222:19 pmRNSPublication of Annual Report and Notice of AGM
7th Apr 20222:18 pmRNSHolding(s) in Company
7th Apr 20229:33 amRNSUpdate regarding the NOMAD condition
7th Apr 20227:00 amRNSUpdate Regarding the Nomad Condition
6th Apr 202211:41 amRNSForm 8.3 - Arden Partners plc
5th Apr 20227:00 amRNSAudited Results for the Year Ended 31 October 2021
18th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI) - AssetCo PLC
14th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 202210:20 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 20229:48 amRNSForm 8.3 - Ince Group PLC
7th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
3rd Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
9th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
4th Feb 20221:03 pmRNSForm 8.5 (EPT/NON-RI)
2nd Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
1st Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20221:00 pmRNSForm 8.5 (EPT/NON-RI)
26th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
21st Jan 20227:00 amRNSApproval of the FCA condition
21st Jan 20227:00 amRNSFCA Approval of the Change of Control
20th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20224:30 pmRNSResults of Arden court meeting & general meeting
19th Jan 20224:24 pmRNSResults of Court Meeting and General Meeting
18th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
17th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 20212:30 pmRNSPublication of Scheme Document
15th Dec 20217:00 amRNSExtension Of Irrevocable Undertakings
8th Dec 20218:00 amRNSExtension Of Irrevocable Undertakings
1st Dec 20212:03 pmRNSForm 8 (DD) - The Ince Group plc
30th Nov 202111:55 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.